CAR-T-derived extracellular vesicles: a promising development of CAR-T anti-tumor therapy

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: In: Cancers (2023) 15:4, 1052. https://doi.org/10.3390/cancers15041052

Event: Veröffentlichung

(where): Würzburg

(who): Universität Würzburg

(when): 2023

Creator: Pagotto, Sara
Simeone, Pasquale
Brocco, Davide
Catitti, Giulia
De Bellis, Domenico
Vespa, Simone
Di Pietro, Natalia
Marinelli, Lisa
Di Stefano, Antonio
Veschi, Serena
De Lellis, Laura
Verginelli, Fabio
Kaitsas, Francesco
Iezzi, Manuela
Pandolfi, Assunta
Visone, Rosa
Tinari, Nicola
Caruana, Ignazio
Di Ianni, Mauro
Cama, Alessandro
Lanuti, Paola
Florio, Rosalba

DOI: 10.3390/cancers15041052

URN: urn:nbn:de:bvb:20-opus-304195

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:26 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Pagotto, Sara
Simeone, Pasquale
Brocco, Davide
Catitti, Giulia
De Bellis, Domenico
Vespa, Simone
Di Pietro, Natalia
Marinelli, Lisa
Di Stefano, Antonio
Veschi, Serena
De Lellis, Laura
Verginelli, Fabio
Kaitsas, Francesco
Iezzi, Manuela
Pandolfi, Assunta
Visone, Rosa
Tinari, Nicola
Caruana, Ignazio
Di Ianni, Mauro
Cama, Alessandro
Lanuti, Paola
Florio, Rosalba
Universität Würzburg

Time of origin

2023

Other Objects (12)

Engineering CAR-T cells

FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer

Preclinical development of CD126 CAR-T cells with broad antitumor activity

Hochschulschrift

Superior anti-tumor efficacy of CD4⁺ CAR-T cells in hematological malignancies

Mesothelin-based CAR-T cells exhibit potent antitumor activity against ovarian cancer

GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer

Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study

Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies

Strategies to enhance CAR-T persistence

Gut microbiome and CAR-T therapy

Target selection for CAR-T therapy

Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma

Engineering CAR-T cells

FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer

Preclinical development of CD126 CAR-T cells with broad antitumor activity

Hochschulschrift

Superior anti-tumor efficacy of CD4⁺ CAR-T cells in hematological malignancies

Mesothelin-based CAR-T cells exhibit potent antitumor activity against ovarian cancer

GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer

Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study

Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies

Strategies to enhance CAR-T persistence

Gut microbiome and CAR-T therapy

Target selection for CAR-T therapy

Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma

Engineering CAR-T cells

FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer

Preclinical development of CD126 CAR-T cells with broad antitumor activity

Hochschulschrift

Superior anti-tumor efficacy of CD4⁺ CAR-T cells in hematological malignancies

Mesothelin-based CAR-T cells exhibit potent antitumor activity against ovarian cancer

GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer

Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study

Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies

Strategies to enhance CAR-T persistence

Gut microbiome and CAR-T therapy

Target selection for CAR-T therapy

Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

CAR-T-derived extracellular vesicles: a promising development of CAR-T anti-tumor therapy

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Engineering CAR-T cells

FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer

Preclinical development of CD126 CAR-T cells with broad antitumor activity

Superior anti-tumor efficacy of CD4⁺ CAR-T cells in hematological malignancies

Mesothelin-based CAR-T cells exhibit potent antitumor activity against ovarian cancer

GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer

Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study

Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies

Strategies to enhance CAR-T persistence

Gut microbiome and CAR-T therapy

Target selection for CAR-T therapy

Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma

Engineering CAR-T cells

FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer

Preclinical development of CD126 CAR-T cells with broad antitumor activity

Superior anti-tumor efficacy of CD4⁺ CAR-T cells in hematological malignancies

Mesothelin-based CAR-T cells exhibit potent antitumor activity against ovarian cancer

GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer

Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study

Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies

Strategies to enhance CAR-T persistence

Gut microbiome and CAR-T therapy

Target selection for CAR-T therapy

Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma

Engineering CAR-T cells

FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer

Preclinical development of CD126 CAR-T cells with broad antitumor activity

Superior anti-tumor efficacy of CD4⁺ CAR-T cells in hematological malignancies

Mesothelin-based CAR-T cells exhibit potent antitumor activity against ovarian cancer

GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer

Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study

Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies

Strategies to enhance CAR-T persistence

Gut microbiome and CAR-T therapy

Target selection for CAR-T therapy

Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma

Related objects

Reset password